Depression News and Research

Latest Depression News and Research

Scientists launch NEWMEDS project to develop drugs for schizophrenia and depression

An international consortium of scientists, led by H. Lundbeck A/S and King's College London, has launched one of the largest ever research academic-industry collaboration projects to find new methods for the development of drugs for schizophrenia and depression.

19 Jan 2010

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

More and more Americans with chronic pain not caused by cancer are taking medically prescribed opioids like Oxycontin (oxycodone) and Vicodin (hydrocodone). The January 19 Annals of Internal Medicine features the first study to explore the risk of overdose in patients prescribed opioids for chronic noncancer pain in general health care.

19 Jan 2010

Sunlight and vitamin D deficiency linked to 17 varieties of cancer

For humans, sunlight and vitamin D is critically important for the development, growth, and maintenance of a healthy body, from birth until death. "Humans make thousands of units of vitamin D within minutes of whole body exposure to sunlight. From what we know of nature, it is unlikely such a system evolved by chance," states Dr. John Cannell, Executive Director, Vitamin D Council.

18 Jan 2010

Study reveals link between serotonin receptor number and antidepressant treatment

An excess of one type of serotonin receptor in the center of the brain may explain why antidepressants fail to relieve symptoms of depression for 50 percent of patients, a new study from researchers at Columbia University Medical Center shows.

18 Jan 2010

New genetic risk factor for Parkinson's disease identified

An international team of doctors and human geneticists has identified a new genetic risk factor for Parkinson's disease. The institutions involved in the study were the Institute of Human Genetics of Helmholtz Zentrum München and Technische Universität München, the Neurological Clinic of Ludwig-Maximilians-Universität Munich (LMU) and the Mitochondrial Research Group of Newcastle University, Newcastle upon Tyne, UK.

18 Jan 2010

Metabolon awarded US Patent for ‘metabolomics methods’

Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 “Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics” by the United States Patent and Trademark Office on December 22, 2009.

18 Jan 2010

New research shows migraine and depression may share common genetic pathways

New research shows that migraine and depression may share a strong genetic component. The research is published in the January 13, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

18 Jan 2010

Portugal life scientist awarded ERC's Advanced Investigator Grant

Zachary Mainen, coordinator of the Champalimaud Foundation Neuroscience Programme at the IGC, has become one of the most recent winners of the prestigious and highly competitive European Research Council grants, to the value of 2.3 million euro, for a period of five years. This grant, which recognises Mainen's contribution to the Neuroscience field, will be used to elucidate the biological role of the neurotransmitter serotonin.

18 Jan 2010

Researchers show close correlation between public health and recreational opportunities

One way to help address the epidemic of obesity in the United States is improved access to pleasant hiking trails and an ambitious parks and recreation program, a recent study suggests, but programs such as this are increasingly being reduced in many states due to budget shortfalls.

18 Jan 2010

Study reveals interaction of genetic and environmental factors in the pathogenesis of Parkinson's disease

"Our study reveals the interaction of genetic and environmental factors such as dietary habits in the pathogenesis of Parkinson's disease," explained Dr. Matthias Elstner of the Neurological Clinic of LMU and Helmholtz Zentrum M-nchen, lead author of the study.

18 Jan 2010

IGC scientist wins ERC grant for neuroscience research

18 Jan 2010

New tools to assess daily stress amongst schoolchildren

Researchers from the University of Malaga have created the 'Inventory of Daily Stressors', a method aimed at schoolchildren. According to experts, worrying about physical appearance, taking part in numerous extracurricular activities and being alone a lot are some of the factors that increase the risk of suffering from childhood stress.

14 Jan 2010

Majority of doctors appear to ignore FDA warning to screen high-risk medications

A new study concludes that many doctors appear to have largely ignored a Food and Drug Administration warning to screen users of new antipsychotic drugs for high blood sugar and cholesterol, which poses risks to their health and raises questions about the efficacy of warning protocols in general.

13 Jan 2010

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today reported that a new clinical study shows that its investigational compound CXB722 has potential as a novel anxiolytic, demonstrating a significant effect on both endocrine and cardiovascular biomarkers associated with stress.

13 Jan 2010

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

New research has shown that reducing the dosage of dopamine agonist (DA) drugs, a mainstay treatment for Parkinson's disease (PD), sometimes causes acute withdrawal symptoms similar to those reported by cocaine addicts -- including anxiety, panic attacks, depression, sweating, nausea, generalized pain, fatigue, dizziness and drug cravings. These symptoms can be severe, and are not alleviated by other PD medications.

12 Jan 2010

NeuroScience launches NEI Guided Nutrition Program

NeuroScience, Inc. has launched a comprehensive and customizable dietary program based on patients' food sensitivity test results. The NEI Guided Nutrition Program(TM) is the first offering through NeuroScience, Inc.'s new NEI Nutrition(TM) division.

12 Jan 2010

Targacept signs collaboration and license agreement with AstraZeneca

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

11 Jan 2010

Tampa Bay Partnership releases new briefs on the economic and business growth in the Tampa Bay Region

SRI International Dedicates New Tampa Bay Research Facility SRI International, one of the world's leading independent research and technology development organizations, officially opened its new 40,000-square-foot research facility located at the Port of St. Petersburg.

11 Jan 2010

EON Reality supports BBU with immersive EON Icube environment for virtual reality therapy project

EON Reality, the world's leading interactive 3D software provider, supports the Babes-Bolyai University (BBU), in Cluj-Napoca, Romania with an immersive EON Icube environment for a virtual reality therapy project.

9 Jan 2010

Neurosurgeons perform world's first operation on 'habenula' to treat depression

A team of neurosurgeons at Heidelberg University Hospital and psychiatrists at the Central Institute of Mental Health, Mannheim have for the first time successfully treated a patient suffering from severe depression by stimulating the habenula, a tiny nerve structure in the brain.

8 Jan 2010

Depression News and Research

Latest Depression News and Research

Scientists launch NEWMEDS project to develop drugs for schizophrenia and depression

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

Sunlight and vitamin D deficiency linked to 17 varieties of cancer

Study reveals link between serotonin receptor number and antidepressant treatment

New genetic risk factor for Parkinson's disease identified

Metabolon awarded US Patent for ‘metabolomics methods’

New research shows migraine and depression may share common genetic pathways

Portugal life scientist awarded ERC's Advanced Investigator Grant

Researchers show close correlation between public health and recreational opportunities

Study reveals interaction of genetic and environmental factors in the pathogenesis of Parkinson's disease

IGC scientist wins ERC grant for neuroscience research

New tools to assess daily stress amongst schoolchildren

Majority of doctors appear to ignore FDA warning to screen high-risk medications

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

NeuroScience launches NEI Guided Nutrition Program

Targacept signs collaboration and license agreement with AstraZeneca

Tampa Bay Partnership releases new briefs on the economic and business growth in the Tampa Bay Region

EON Reality supports BBU with immersive EON Icube environment for virtual reality therapy project

Neurosurgeons perform world's first operation on 'habenula' to treat depression

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Depression News and Research

Latest Depression News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in